These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9422998)

  • 21. Metabolic modulation for cardiac protection.
    Weinberg GL; Massad MG
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):135-8. PubMed ID: 17338658
    [No Abstract]   [Full Text] [Related]  

  • 22. [Retrograde protection of the myocardium in cardiac surgery].
    Semagin AP
    Khirurgiia (Mosk); 1989 Jan; (1):114-8. PubMed ID: 2649735
    [No Abstract]   [Full Text] [Related]  

  • 23. [Ion-balanced cardioplegic solutions in cardiac surgery].
    Zorin AB; Efremenkov EA; Kurapeev IS; Lobkov AV; Lubiako AA; Novikov VK; Onishchenko NA; Pimenov AV
    Vestn Khir Im I I Grek; 1989 Sep; 143(9):104-7. PubMed ID: 2617761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. eComment: myocardial protection: efficacy of a novel magnesium-basedcardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
    Bockeria LA; Movsesyan RR; Ryabtsev DV; Grigoryants TR
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):749. PubMed ID: 18801803
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravenous glucose-insulin-potassium during off-pump coronary artery bypass surgery does not reduce myocardial injury.
    Shim YH; Kweon TD; Lee JH; Nam SB; Kwak YL
    Acta Anaesthesiol Scand; 2006 Sep; 50(8):954-61. PubMed ID: 16923090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cardioplegia by minicardioplegia technique].
    Türköz R; Gülcan O; Türköz A
    Anadolu Kardiyol Derg; 2006 Jun; 6(2):178-9. PubMed ID: 16766286
    [No Abstract]   [Full Text] [Related]  

  • 27. [Myocardial protection in open heart surgery with special consideration for Kurume cardioplegic solution].
    Oishi K; Akagawa H; Hoshino Y; Ishino T; Tajiri T
    Rinsho Kyobu Geka; 1982; 2(1):9-17. PubMed ID: 7156720
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of glucose-insulin-potassium infusion on plasma free fatty acid concentrations in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Addo TA; Keeley EC; Cigarroa JE; Lange RA; de Lemos JA; Dobbins RL; McGuire DK
    Am J Cardiol; 2004 Nov; 94(10):1288-9. PubMed ID: 15541248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardioplegia controversies.
    Noble WH; Lichtenstein SV; Mazer CD
    Can J Anaesth; 1991 Jan; 38(1):1-6. PubMed ID: 1899201
    [No Abstract]   [Full Text] [Related]  

  • 30. Glucose-insulin-potassium therapy in patients with STEMI.
    Opie LH
    JAMA; 2008 May; 299(20):2385-6; author reply 2387-8. PubMed ID: 18505941
    [No Abstract]   [Full Text] [Related]  

  • 31. Membrane polarity: a target for myocardial protection and reduced inflammation in adult and pediatric cardiothoracic surgery.
    Dobson GP
    J Thorac Cardiovasc Surg; 2010 Dec; 140(6):1213-7. PubMed ID: 20605029
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of perfusion volume of the Custodiol solution on the efficiency of cardioplegia in experiment].
    Zhidkov IL; Belianko IE; Sitnichenko NV; Paliulina MV; Laptiĭ AV
    Anesteziol Reanimatol; 2008; (5):42-7. PubMed ID: 19102231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do we need hypothermia in myocardial protection?
    Yamamoto F
    Ann Thorac Cardiovasc Surg; 2000 Aug; 6(4):216-23. PubMed ID: 11042476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Glucose-insulin-potassium (GIK) solution: cardioprotective effects of insulin].
    Rojas Pérez EM; Luna Ortiz P; Serrano Valdez X; Fernández Rivera BJ; de Micheli A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S144-51. PubMed ID: 17469342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
    Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
    Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Warm heart surgery: reflections on the history of its development.
    Salerno TA
    J Card Surg; 2007; 22(3):257-9. PubMed ID: 17488433
    [No Abstract]   [Full Text] [Related]  

  • 38. [A comparative study of myocardial protective methods during open heart surgery (author's transl)].
    Shiguma S
    Nihon Kyobu Geka Gakkai Zasshi; 1980 Dec; 28(12):1803-39. PubMed ID: 7007530
    [No Abstract]   [Full Text] [Related]  

  • 39. Myocardial protection and cardiopulmonary bypass in neonates and infants.
    del Nido PJ
    Ann Thorac Surg; 1997 Sep; 64(3):878-9. PubMed ID: 9307504
    [No Abstract]   [Full Text] [Related]  

  • 40. Invited commentary.
    Modi P; Suleiman MS
    Ann Thorac Surg; 2009 May; 87(5):1523-4. PubMed ID: 19379897
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.